Form 4: Maravai LifeSciences CFO Kevin Herde Sells Shares to Cover Tax Obligations

Maravai LifeSciences CFO Kevin Herde sold 46,344 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.

Summary

• Kevin Herde, the Chief Financial Officer of Maravai LifeSciences Holdings, Inc., sold 46,344 shares of Class A Common Stock on January 15, 2025.
• The sale was executed at a price of $4.56 per share.
• This transaction was to cover tax withholding obligations associated with the vesting of restricted stock unit awards.
• Following the transaction, Mr. Herde directly owns 290,256 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the industry.
• The number of shares sold is not unusual for a CFO of a company of this size.
• The price of $4.56 per share is reflective of the current market price of the stock at the time of the transaction.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Maravai LifeSciences, MRVI, Kevin Herde, CFO, stock sale, insider trading, Form 4, tax obligations, restricted stock units